Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23448807 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
Conditions: Carcinoma, Pancreatic Ductal;   Pancreatic Cancer;   Pancreatic Disease
Interventions: Biological: AGS-1C4D4;   Biological: Gemcitabine

Indicates status has not been verified in more than two years